| scholarly article | Q13442814 |
| P2093 | author name string | Janzon L | |
| Berglund G | |||
| Nilsson P | |||
| Hedblad B | |||
| Engström G | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR). | Q31901715 | ||
| Insulin resistance: an independent risk factor for cardiovascular disease? | Q34163104 | ||
| Insulin and atheroma. 20-yr perspective | Q37934803 | ||
| Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study | Q39473892 | ||
| Intra-urban variations in incidence and mortality in myocardial infarction. A study from the myocardial infarction register in the city of Malmö, Sweden | Q39484083 | ||
| Cardiovascular risk factors and the prediabetic syndrome | Q41156161 | ||
| A questionnaire for the assessment of leisure time physical activities | Q42126994 | ||
| Intact insulin, insulin propeptides, and intima-media thickness in the femoral artery in 58-year-old clinical healthy men--the Atherosclerosis and Insulin Resistance Study | Q43593322 | ||
| Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study | Q46140379 | ||
| Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q47381195 | ||
| Insulin and risk of cardiovascular disease: a meta-analysis | Q49102279 | ||
| Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. | Q50864806 | ||
| A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. | Q50953901 | ||
| Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. | Q50962953 | ||
| A prospective analysis of the HOMA model. The Mexico City Diabetes Study. | Q50997121 | ||
| Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. | Q51556160 | ||
| The homeostasis model in the San Antonio Heart Study. | Q51574832 | ||
| Insulin resistance as an independent risk factor for carotid wall thickening. | Q51579378 | ||
| Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. | Q51581413 | ||
| Prospective analysis of the insulin-resistance syndrome (syndrome X). | Q51605494 | ||
| P433 | issue | 6 | |
| P921 | main subject | myocardial infarction | Q12152 |
| preproinsulin | Q7240673 | ||
| insulin resistance | Q1053470 | ||
| P304 | page(s) | 470-475 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Diabetic Medicine | Q15758639 |
| P1476 | title | Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death | |
| P478 | volume | 19 |
| Q79761759 | 24-h ambulatory blood pressure is linked to chromosome 18q21-22 and genetic variation of NEDD4L associates with cross-sectional and longitudinal blood pressure in Swedes |
| Q37050689 | A High Diet Quality Based on Dietary Recommendations Is Not Associated with Lower Incidence of Type 2 Diabetes in the Malmö Diet and Cancer Cohort |
| Q37360454 | A variant in the KCNQ1 gene predicts future type 2 diabetes and mediates impaired insulin secretion |
| Q33304235 | Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis |
| Q43839198 | Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS. |
| Q57271602 | Association between fat intake, physical activity and mortality depending on genetic variation in FTO |
| Q93064086 | Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes |
| Q50032526 | Association between single nucleotide polymorphism rs11057401 of CCDC92 gene and the risk of coronary heart disease (CHD). |
| Q37246522 | Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004 |
| Q36281537 | Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies |
| Q47430759 | Changes in blood pressure and body weight following smoking cessation in women |
| Q34139222 | Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms of Males and Females in the Aspect of Gender-Specific Medicine: A Single Institutional Study |
| Q78621007 | Current literature in diabetes |
| Q57271604 | Dairy products and its association with incidence of cardiovascular disease: the Malmö diet and cancer cohort |
| Q47920529 | Effect of Tamsulosin in Lower Urinary Tract Symptom Patients With Metabolic Syndrome |
| Q51351064 | Effect of a common variant of the PCSK2 gene on reduced insulin secretion. |
| Q36016946 | FFAs: do they play a role in vascular disease in the insulin resistance syndrome? |
| Q51257461 | Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis. |
| Q51579426 | Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. |
| Q43247373 | HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study |
| Q36444808 | HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study |
| Q84302234 | Homeostasis model assessment of insulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men |
| Q36052078 | Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation |
| Q33296042 | Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women |
| Q34564051 | Insulin resistance and adipokines serum levels in a caucasian cohort of hiv-positive patients undergoing antiretroviral therapy: a cross sectional study. |
| Q92480445 | Insulin resistance and dysglycemia are associated with left ventricular remodeling after myocardial infarction in non-diabetic patients |
| Q33698416 | Insulin resistance and triglyceride/HDLc index are associated with coronary artery disease |
| Q35712246 | Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study |
| Q37374628 | Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction |
| Q33873016 | Insulin resistance predicts mortality in nondiabetic individuals in the U.S. |
| Q35976473 | Insulin resistance, cystatin C, and mortality among older adults |
| Q35578858 | Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers |
| Q44616454 | Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes? |
| Q37729655 | Lifestyle and Dietary Determinants of Serum Apolipoprotein A1 and Apolipoprotein B Concentrations: Cross-Sectional Analyses within a Swedish Cohort of 24,984 Individuals |
| Q47819647 | Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study |
| Q79399948 | Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant rats |
| Q34566559 | Loss of canonical insulin signaling accelerates vascular smooth muscle cell proliferation and migration through changes in p27Kip1 regulation |
| Q53933471 | Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. |
| Q37017696 | Measurement of insulin resistance in chronic kidney disease |
| Q40202608 | Metabolic Syndrome and Lower Urinary Tract Symptoms: Epidemiological Study |
| Q45063587 | Metabolic syndrome in patients with coronary heart disease. Results of using different diagnostic criteria |
| Q37230510 | N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population |
| Q36490365 | Percutaneous coronary intervention for revascularization of the diabetic patient |
| Q30829502 | Physical activity and metabolic health in chronic kidney disease: a cross-sectional study |
| Q34625239 | Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial |
| Q30941905 | Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies |
| Q35584209 | Post-challenge hyperinsulinaemia rather than hyperglycaemia is associated with the severity of coronary artery disease in patients without a previous diagnosis of diabetes mellitus |
| Q45133921 | Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome |
| Q40085569 | Relationship between estimated cardiovascular disease risk and insulin resistance in a black African population living with HIV: a cross-sectional study from Cameroon. |
| Q37302273 | Relationship between insulin resistance and subclinical atherosclerosis in individuals with and without type 2 diabetes mellitus |
| Q41497141 | Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. |
| Q37110579 | Relaxin treatment reverses insulin resistance in mice fed a high-fat diet |
| Q51477941 | Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. |
| Q64112606 | Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies |
| Q40247441 | Should insulin resistance be screened in lean hirsute women? |
| Q34615287 | The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients |
| Q37291570 | The antihypertensive effect of cysteine |
| Q55175780 | The association between insulin resistance, metabolic syndrome, and ischemic heart disease among Rumoi residents. |
| Q36800292 | The association of intensity and overall level of physical activity energy expenditure with a marker of insulin resistance |
| Q41613658 | The associations between increasing degrees of homeostatic model assessment for insulin resistance and muscular strengthening activities among euglycaemic US adults |
| Q27002724 | The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases |
| Q35731801 | The mechanisms by which antidepressants may reduce coronary heart disease risk |
| Q58271154 | The metabolic syndrome and cardiovascular disease |
| Q48811744 | The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study |
| Q43609875 | The risk for coronary heart disease according to insulin resistance with and without type 2 diabetes |
| Q36108506 | Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance |
| Q36844077 | Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease |
| Q51327721 | Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function. |
| Q53922658 | [Prevalence of metabolic syndrome in patients with coronary heart disease]. |
Search more.